2009
DOI: 10.1164/rccm.200807-1126oc
|View full text |Cite|
|
Sign up to set email alerts
|

Severe Exacerbations and Decline in Lung Function in Asthma

Abstract: Severe asthma exacerbations are associated with a more rapid decline in lung function. Treatment with low doses of inhaled corticosteroid is associated with an attenuation of the decline.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

8
308
9
10

Year Published

2010
2010
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 409 publications
(335 citation statements)
references
References 21 publications
8
308
9
10
Order By: Relevance
“…In our study FEV 1 declined 17.4 ml/year faster, and FVC declined 14.3 ml/year faster in the low activity group. Sex (male), high frequency of disease exacerbations, old age, absence of glucocorticoid treatment, and smoking have been found to accelerate FEV 1 decline in asthmatics [9,36,37]. After adjusting for these factors with multiple linear regression analysis, the association of physical activity with FEV 1 decline remained significant.…”
Section: Discussionmentioning
confidence: 99%
“…In our study FEV 1 declined 17.4 ml/year faster, and FVC declined 14.3 ml/year faster in the low activity group. Sex (male), high frequency of disease exacerbations, old age, absence of glucocorticoid treatment, and smoking have been found to accelerate FEV 1 decline in asthmatics [9,36,37]. After adjusting for these factors with multiple linear regression analysis, the association of physical activity with FEV 1 decline remained significant.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, they attenuate the decline in lung function seen in association with severe exacerbations 86 . Fewer comparative studies have been conducted in children 5 years and younger.…”
Section: Inhaled Glucocorticosteroids and Cromolynmentioning
confidence: 99%
“…In fact, exacerbations are the main cause of morbidity and mortality in patients with asthma [5], thus increasing the annual cost of treatment 3-fold [6]. Patients who have frequent exacerbations usually experience an accelerated loss of lung function [7].…”
Section: Introductionmentioning
confidence: 99%